Dexlansoprazole Capsule, Delayed Release
Product Images NDC 51407-747

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 51407-747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-746-30.jpg (51407 746 30)

51407-746-30.jpg (51407 746 30)
This is a prescription drug with the NDC code 51407-746-30 in the form of delayed-release capsules, containing 30mg of Dexlansoprazole as enteric-coated granules. The medication guide should be printed from https://gsms.us/ and given to patients by the pharmacist. The recommended dosage should be obtained from the accompanying prescribing information. The capsules should be stored in a light-resistant, tightly sealed container between 20°C to 25°C (68°F to 77°F) and kept out of the reach of children. The manufacturer is GSMS, Incorporated, and this information is revised as of 03/23.*
FDA Label Image

51407-747-30.jpg (51407 747 30)

51407-747-30.jpg (51407 747 30)
This is a medication called Dexlansoprazole available in the form of Delayed-Release Capsules. Each capsule contains 60 mg of Dexlansoprazole. The medication guide needs to be dispensed to each patient by the pharmacist. The dosage needs to be determined as per the accompanying Prescribing Information. It needs to be stored in a tight, light-resistant container at 20° - 25°C (68° - 77°F). This medication is distributed by GSMS, Incorporated in Camarillo, CA 93012 USA.*
FDA Label Image

Chemical Structure (Dexlansoprazole 01)

FDA Label Image

Figure 1 (Dexlansoprazole 02)

Figure 1 (Dexlansoprazole 02)
This is a graph showing plasma concentration (in ng/mL) of Dexlansoprazole at 30mg and 60mg over time (in hours). The concentrations decrease over time for both doses.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.